You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Details for Patent: 9,498,465


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,498,465 protect, and when does it expire?

Patent 9,498,465 protects AKLIEF and is included in one NDA.

This patent has eleven patent family members in eleven countries.

Summary for Patent: 9,498,465
Title:Topical compositions in the form of a gel containing a particular solubilized retinoid
Abstract: A composition in the form of a gel, preferably hydroglycolic, is described. The composition can include in a physiologically acceptable medium, at least one particular retinoid. Also described, is a method for the preparation thereof and the cosmetic and dermatological use of the same.
Inventor(s): Duprat; Agnes (Mougins, FR), Mallard; Claire (Mougins, FR)
Assignee: GALDERMA RESEARCH & DEVELOPMENT (Boit, FR)
Application Number:14/404,913
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 9,498,465

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp AKLIEF trifarotene CREAM;TOPICAL 211527-001 Oct 4, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y TOPICAL TREATMENT OF ACNE VULGARIS ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,498,465

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France12 55092Jun 1, 2012
PCT Information
PCT FiledMay 30, 2013PCT Application Number:PCT/EP2013/061200
PCT Publication Date:December 05, 2013PCT Publication Number: WO2013/178759

International Family Members for US Patent 9,498,465

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013269582 ⤷  Try a Trial
Brazil 112014029879 ⤷  Try a Trial
Canada 2874270 ⤷  Try a Trial
China 104507471 ⤷  Try a Trial
European Patent Office 2854803 ⤷  Try a Trial
France 2991176 ⤷  Try a Trial
Japan 2015518034 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.